Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,533
archived clinical trials in
Kidney Cancer

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Cardinal Glennon Children's Medical Center
mi
from
Saint Louis, MO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Cardinal Glennon Children's Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint John's Mercy Medical Center
mi
from
Saint Louis, MO
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint John's Mercy Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital and Medical Center of Omaha
mi
from
Omaha, NE
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital and Medical Center of Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Hackensack University Medical Center
mi
from
Hackensack, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Barnabas Medical Center
mi
from
Livingston, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Barnabas Medical Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Morristown Memorial Hospital
mi
from
Morristown, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
UMDNJ-Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
UMDNJ-Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Newark Beth Israel Medical Center
mi
from
Newark, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Joseph's Regional Medical Center
mi
from
Paterson, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Joseph's Regional Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Overlook Hospital
mi
from
Summit, NJ
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Overlook Hospital
mi
from
Summit, NJ
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Winthrop University Hospital
mi
from
Mineola, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Steven & Alexandra Cohen Children's Medical Center of New York
mi
from
New Hyde Park, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Steven & Alexandra Cohen Children's Medical Center of New York
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
New York University Langone Medical Center
mi
from
New York, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Mount Sinai Hospital
mi
from
New York, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Columbia University Medical Center
mi
from
New York, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Weill Medical College of Cornell University
mi
from
New York, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Rochester
mi
from
Rochester, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
New York Medical College
mi
from
Valhalla, NY
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
East Carolina University
mi
from
Greenville, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Sanford Medical Center-Fargo
mi
from
Fargo, ND
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Sanford Medical Center-Fargo
mi
from
Fargo, ND
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Rainbow Babies and Children's Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Toledo Children's Hospital
mi
from
Toledo, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Toledo Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Mercy Children's Hospital
mi
from
Toledo, OH
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Mercy Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Randall Children's Hospital at Legacy Emanuel
mi
from
Portland, OR
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Randall Children's Hospital at Legacy Emanuel
mi
from
Portland, OR
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Oregon Health and Science University
mi
from
Portland, OR
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Geisinger Medical Center
mi
from
Danville, PA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Penn State Hershey Children's Hospital
mi
from
Hershey, PA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Penn State Hershey Children's Hospital
mi
from
Hershey, PA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Saint Christopher's Hospital for Children
mi
from
Philadelphia, PA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Saint Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated:  5/18/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Enrolling
Updated: 5/18/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials